Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 32.90% is 11% below its 5-year average of 36.99%, around the middle of its 5-year range (25.45%–42.91%).
As of the fiscal period ended Tuesday, March 31, 2026. 5.05% below its 12-month average of 34.65%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
32.90%
GROSS MARGIN AVG TTM
34.65%
GROSS MARGIN AVG 3Y
37.90%
GROSS MARGIN AVG 5Y
36.99%
GROSS MARGIN AVG 10Y
37.25%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.05%
CURRENT VS 3Y AVG
-13.17%
CURRENT VS 5Y AVG
-11.05%
CURRENT VS 10Y AVG
-11.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.69%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-43.94%
vs the sector median at left
Market Cap
$22.03B
Gross Margin
86.58%
TTM Avg
88.58%
3Y Avg
89.63%
5Y Avg
90.66%
Market Cap
$18.99B
Gross Margin
61.62%
TTM Avg
66.54%
3Y Avg
68.95%
5Y Avg
69.55%
Market Cap
$24.28B
Gross Margin
92.62%
TTM Avg
92.70%
3Y Avg
93.10%
5Y Avg
93.74%
Market Cap
$16.41B
Gross Margin
28.76%
TTM Avg
30.59%
3Y Avg
29.65%
5Y Avg
29.57%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $20.55B | 32.90% | 34.65% | 37.90% | 36.99% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 86.58% | 88.58% | 89.63% | 90.66% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.99B | 61.62% | 66.54% | 68.95% | 69.55% |
| Moderna, Inc. (MRNA)vs › | $22.32B | 55.35% | 54.80% | 53.09% | 65.45% |
| STERIS plc (STE)vs › | $22.68B | 44.25% | 44.13% | 43.77% | 43.82% |
| BioNTech SE (BNTX)vs › | $23.16B | 73.26% | 78.98% | 81.24% | 82.89% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 61.00% | 58.14% | 57.33% | 59.28% |
| Incyte Corporation (INCY)vs › | $24.28B | 92.62% | 92.70% | 93.10% | 93.74% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 28.76% | 30.59% | 29.65% | 29.57% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 36.77% | 35.27% | 37.10% | 37.60% |
Gross Margin
32.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 32.90% |
| 2025-12-31 | 30.63% |
| 2025-09-30 | 36.83% |
| 2025-06-30 | 37.21% |
| 2025-03-31 | 35.68% |
| 2024-12-31 | 34.44% |
| 2024-09-30 | 38.90% |
| 2024-06-30 | 38.07% |
| 2024-03-31 | 41.05% |
| 2023-12-31 | 41.60% |
| 2023-09-30 | 42.91% |
| 2023-06-30 | 41.05% |
| 2023-03-31 | 41.36% |
| 2022-12-31 | 32.87% |
| 2022-09-30 | 42.87% |
| 2022-06-30 | 41.37% |
| 2022-03-31 | 42.25% |
| 2021-12-31 | 35.62% |
| 2021-09-30 | 34.70% |
| 2021-06-30 | 29.00% |
| 2021-03-31 | 25.45% |
| 2020-12-31 | 19.49% |
| 2020-09-27 | 38.98% |
| 2020-06-28 | 37.55% |
| 2020-03-29 | 34.59% |
| 2019-12-31 | 34.07% |
| 2019-09-29 | 36.21% |
| 2019-06-29 | 32.71% |
| 2019-03-30 | 32.27% |
| 2018-12-30 | 32.99% |
| 2018-09-29 | 36.31% |
| 2018-06-29 | 34.27% |
| 2018-03-30 | 36.67% |
| 2017-12-30 | 39.97% |
| 2017-09-29 | 39.44% |
| 2017-06-29 | 41.37% |
| 2017-03-30 | 39.90% |
| 2016-12-30 | 40.85% |
| 2016-09-29 | 41.98% |
| 2016-06-29 | 45.76% |
| 2016-03-30 | 41.39% |
| 2015-12-30 | 42.66% |
| 2015-09-29 | 48.80% |
| 2015-06-29 | 42.51% |
| 2015-03-30 | 44.35% |
| 2014-12-30 | 46.53% |
| 2014-09-29 | 48.58% |
| 2014-06-29 | 44.02% |
| 2014-03-30 | 43.01% |
| 2013-12-30 | 44.01% |
| 2013-09-29 | 45.75% |
